COVID-19 and acute mesenteric ischemia: A review of literature
AUTOR(ES)
Singh, Balraj; Kaur, Parminder
FONTE
Hematol., Transfus. Cell Ther.
DATA DE PUBLICAÇÃO
2021-03
RESUMO
ABSTRACT Introduction: von Willebrand's disease (VWD) is the most common inherited bleeding disorder. The 1-desamino-8-d-arginine vasopressin (DDAVP) is the treatment of choice for most responsive patients with VWD. The aim of this study was to evaluate DDAVP use in the management of VWD. Method: We implemented a survey targeting medical doctors involved in the management of VWD in Brazil. Data was collected during a national congress on Hematology in November 2017. Main results: A total of 51/80 (63.8%) questionnaires were collected. Most participants (76.2%) were hematologists who assisted adult patients and approximately 60% worked at hemophilia treatment centers (HTCs). Approximately half of participants who reported treating patients with VWD, assisted on average, less than 5 patients per month, and approximately 60% declared not having used any DDAVP for treating VWD in the previous year. However, most participants (70%) prescribed FVIII-containing VWF concentrate (VWF/FVIII) for 1-10 patients in the previous year. More than 80% of the participants recognized the main indications for DDAVP. Physicians who recognized indication for DDAVP for type 1 VWD more often had prescribed DDAVP in previous year (p = 0.03). Barriers for prescribing DDAVP varied and included unavailability of laboratory facilities and consumables for DDAVP testing and lack of skills on its prescription. Conclusion: The DDAVP is currently underused in Brazil, as opposed to the excessive use of VWF/FVIII in VWD patients. We suggest the adoption of measures targeting educational and auditing programs. Furthermore, availability of laboratory reagents is needed to evaluate response and increment the correct use of DDAVP.
Documentos Relacionados
- Extracorporeal Membrane Oxygenation in COVID-19 Treatment: a Systematic Literature Review
- Health of the Newborn and Breastfeeding during the COVID-19 Pandemic: A Literature Review
- ABO blood group association and COVID-19. COVID-19 susceptibility and severity: a review
- Acute kidney injury outcomes in covid-19 patients: systematic review and meta-analysis
- Ocular manifestations of COVID-19: a literature review